November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
August 9, 2026 - 08:50
Teledyne Prepares End-to-End Space and Missile Defense Technology Display for 2026 SMD SymposiumTeledyne Technologies has confirmed it will bring a comprehensive display of its space, missile defense, and advanced sensing capabilities to the 2026 Space and Missile Defense Symposium. The event...
August 8, 2026 - 18:14
In California, residents say their city approved a 'technology park,' not a data centerResidents in a California community are pushing back against a project they say was sold to them as a `technology park` but is actually a massive data center complex. The distinction matters, they...
August 8, 2026 - 00:25
The Pennant Group Leverages Technology in Hospice GrowthThe Pennant Group is betting big on technology as it works to keep pace with growing demand in its hospice and home health divisions. The company, which operates a network of senior living and...
August 7, 2026 - 03:21
Technology Expands ICE’s Capacity for AbuseOn July 15, U.S. Representatives Delia Ramirez and Hank Johnson led a shadow hearing focused on how Immigration and Customs Enforcement (ICE) has adopted new technologies that expand its...